Could the applicable patients in the current Phase 3 Trial be added to a new trial. | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49462 of 49859  at  5/16/2019 9:06:20 AM  by

Bibliobiftek


 In response to msg 49459 by  erniewerner
view thread

Re: Could the applicable patients in the current Phase 3 Trial be added to a new trial.

I think the FR-alpha high subgroup data from FORWARD I would support BTD at the FDA. Anna B. brushed aside the question, and they say they are focusing on designing the PIII; however I think they could and should apply for the designation.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 210
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...